Rolicyclidine

This classification denotes a sedative and hypnotic with the molecular formula C16H23N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 183O9O9JE3, chemically known as pyrrolidine, 1-(1-phenylcyclohexyl)- but generally known as rolicyclidine, which bears US NIH Compound Identifier 62436. European Medicines Agency schedules Rolicyclidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10365MIG. The term ROLICYCLIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). ROLICYCLIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rolicyclidine under HS 29339990 and SITC 51577. As of Q4 2014, ROLICYCLIDINE remains the US FDA Preferred Term for this commodity. Rolicyclidine bears US NLM identifiers UMLS ID C2699095 and NCI Concept Code C74374. SMILES: N1(C2(CCCCC2)C2CCCCC2)CCCC1.